Skip to main content
. 2017 Jan 19;9(3):393–403. doi: 10.1080/19420862.2017.1281505

Table 1.

Pharmacokinetic parameters of KP3 Fc variants following 10 mg/kg IV in mice. ND: not determined because of data fluctuation; Cmax = maximal observed concentration; AUClast = area under the concentration time curve up to the last measurable concentration; AUC∞ = Area under the curve from time zero to infinity; T1/2 = terminal phase elimination half- life; CL = systemic clearance; IV = intravenous injection.

Test Articles Cmax (µg/mL) AUClast (day*µg/mL) AUCinf (day*µg/mL) CL (mL/day/kg) T1/2 (day)
KP3-IgG 110.20 99.02 106.61 93.80 2.19
KP3-IgG-2Fc-Half 70.40 116.00 ND ND ND
KP3-IgG-2Fc-Full 60.70 30.66 32.99 303.16 2.21
KP3-IgG-3Fc 8.82 10.82 12.82 779.92 2.69